Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Newell

Showing results (321-330 of 519) with videos related to

Pageof 52
Sort By:
BMC Health Services Research|April 20, 2023
Behavioural change interventions encouraging clinicians to reduce carbon emissions in clinical activity: a systematic reviewCarys Batcup, Matilde Breth-Petersen, Thomas Dakin, et al.
Cancer Research|April 1, 1984
Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal functionS J Harland, D R Newell, Z H Siddik, et al.
British Journal of Cancer|September 5, 2001
Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogueN R Monks, D C Blakey, N J Curtin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activationC J Rutty, I R Judson, G Abel, et al.
Journal of Medicinal Chemistry|January 1, 1989
Quinazoline antifolates inhibiting thymidylate synthase: synthesis of four oligo(L-gamma-glutamyl) conjugates of N10-propargyl-5,8-dideazafolic acid and their enzyme inhibitionK Pawelczak, T R Jones, M Kempny, et al.
Journal of Medicinal Chemistry|April 1, 1989
Quinazoline antifolates inhibiting thymidylate synthase: 2-desamino derivatives with enhanced solubility and potencyT R Jones, T J Thornton, A Flinn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Carboplatin and etoposide pharmacokinetics in patients with testicular teratomaD R Newell, R A Eeles, L A Gumbrell, et al.
Analytical Biochemistry|August 1, 1988
Development of an assay for the estimation of N10-propargyl-5,8-dideazafolic acid polyglutamates in tumor cellsE Sikora, D R Newell, A L Jackman, et al.
Hematological Oncology|March 1, 1993
Pharmacokinetics of high dose methylprednisolone and use in hematological malignanciesP M Patel, P J Selby, M A Graham, et al.
Journal of Medicinal Chemistry|July 1, 1984
Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activityD E Wilman, P J Cox, P M Goddard, et al.
Pageof 52

Showing results (321-330 of 519) with videos related to

Sort By:
Pageof 52
BMC Health Services Research|April 20, 2023
Behavioural change interventions encouraging clinicians to reduce carbon emissions in clinical activity: a systematic reviewCarys Batcup, Matilde Breth-Petersen, Thomas Dakin, et al.
Cancer Research|April 1, 1984
Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal functionS J Harland, D R Newell, Z H Siddik, et al.
British Journal of Cancer|September 5, 2001
Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogueN R Monks, D C Blakey, N J Curtin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activationC J Rutty, I R Judson, G Abel, et al.
Journal of Medicinal Chemistry|January 1, 1989
Quinazoline antifolates inhibiting thymidylate synthase: synthesis of four oligo(L-gamma-glutamyl) conjugates of N10-propargyl-5,8-dideazafolic acid and their enzyme inhibitionK Pawelczak, T R Jones, M Kempny, et al.
Journal of Medicinal Chemistry|April 1, 1989
Quinazoline antifolates inhibiting thymidylate synthase: 2-desamino derivatives with enhanced solubility and potencyT R Jones, T J Thornton, A Flinn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Carboplatin and etoposide pharmacokinetics in patients with testicular teratomaD R Newell, R A Eeles, L A Gumbrell, et al.
Analytical Biochemistry|August 1, 1988
Development of an assay for the estimation of N10-propargyl-5,8-dideazafolic acid polyglutamates in tumor cellsE Sikora, D R Newell, A L Jackman, et al.
Hematological Oncology|March 1, 1993
Pharmacokinetics of high dose methylprednisolone and use in hematological malignanciesP M Patel, P J Selby, M A Graham, et al.
Journal of Medicinal Chemistry|July 1, 1984
Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activityD E Wilman, P J Cox, P M Goddard, et al.
Pageof 52